Decitabine combined with <scp>RDHAP</scp> regimen in relapsed/refractory diffuse large B cell lymphomaXiaoshuang Kong, Linan Zhu, Meng Dong et al.|Cancer Medicine|2023Cited by 10
SUV39H1 is a prognosis and immune microenvironment-related biomarker in diffuse large B-cell lymphomaYue Zhang, Qingjiang Chen, Siyu Qian et al.|Clinical & Translational Oncology|2023Cited by 6